Enterprise Value
18.9M
Cash
2.291M
Avg Qtr Burn
-4.06M
Short % of Float
46.57%
Insider Ownership
4.61%
Institutional Own.
0.39%
Qtr Updated
03/31/24
Drug Pipeline
Powered by
![](/BPIQ_Pill.png)
Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|---|---|
Lomecel-B Details Hypoplastic Left Heart Syndrome | Phase 2a Data readout | |
Lomecel-B Details Alzheimer's disease | Phase 2a Data readout | |
Lomecel-B Details Aging Frailty | Failed Discontinued | |
Lomecel-B Details Acute respiratory distress syndrome | Failed Discontinued |